Table 1.
Hospitalizations involving AWS, No. | AWS Prevalence % (95% CI) | |
---|---|---|
Overall | 26,381 | 5.8 (5.2–6.4) |
Geographic Region | ||
New England | 2,106 | 11.2 (6.9–15.5) |
Middle Atlantic | 2,081 | 4.6 (3.3–5.8) |
South Atlantic | 6,099 | 5.3 (4.1–6.4) |
South | 5,470 | 6.2 (4.7–7.7) |
Midwest | 5,648 | 6.1 (4.9–7.3) |
West | 2,442 | 5.9 (4.4–7.4) |
Northwest | 768 | 5.2 (2.4–8.1) |
Southwest | 1,767 | 4.3 (2.8–5.8) |
Facility Complexity Level | ||
1a—highest | 13,650 | 5.2 (4.4–5.9) |
1b—high | 4,741 | 5.6 (4.4–6.9) |
1c—mid-high | 5,191 | 6.8 (5.3–8.2) |
2—medium | 2,799 | 6.3 (4.6–7.9) |
Intensive care | 1,383 | 3.3 (2.8–3.7) |
Admitting specialty | ||
Medical | 13,478 | 4.4 (4.0–4.8) |
Psychiatric | 12,305 | 19.0 (17.5–20.4) |
Surgical | 598 | 0.7 (0.6–0.8) |
Diagnoses | ||
Alcohol-related disorder | 25,039 | 38.3 (35.8–40.8) |
Other substance use condition | 9,024 | 19.3 (17.7–20.9) |
Suicide attempt | 204 | 15.3 (13.0–17.6) |
Liver injury | 7,073 | 13.9 (12.6–15.1) |
Seizure | 1,870 | 11.9 (10.7–13.1) |
Mental health disorder | 17,363 | 11.6 (10.6–12.7) |
Pancreaticobiliary disease | 1,655 | 8.6 (7.7–9.5) |
Nutrition, electrolyte, or acid-base disorder | 7,949 | 6.5 (5.9–7.2) |
Gastrointestinal tract disorder | 7,776 | 5.1 (4.6–5.6) |
Musculoskeletal or soft tissue disorder | 8,339 | 4.8 (4.3–5.3) |
Trauma | 2,134 | 4.8 (4.3–5.3) |
Chronic obstructive pulmonary disease | 4,357 | 4.6 (4.1–5.1) |
Cardiac dysrhythmia | 2,653 | 2.8 (2.5–3.1) |
Sepsis/shock | 919 | 2.8 (2.5–3.1) |
Pneumonia | 887 | 2.4 (2.1–2.7) |
Diabetes mellitus | 3,278 | 2.2 (2.0–2.5) |
Kidney injury | 2,166 | 1.8 (1.6–2.0) |
Cerebrovascular disease | 527 | 1.8 (1.6–2.1) |
Myocardial infarction | 386 | 1.7 (1.5–2.0) |
Malignancy | 830 | 1.4 (1.2–1.6) |
Congestive heart failure | 917 | 1.3 (1.1–1.5) |
AWS = Alcohol Withdrawal Syndrome, VHA = Veterans Health Administration
Prevalence estimates are adjusted for intraclass correlations using fixed effects at the regional network-level and random effects at the hospital-level